Exploring Alternative Radiolabeling Strategies for Sialic Acid-Binding Immunoglobulin-Like Lectin 9 Peptide: [68Ga]Ga- and [18F]AlF-NOTA-Siglec-9.
Olli MoisioRiikka SiitonenHeidi LiljenbäckElli SuomelaSirpa JalkanenXiang-Guo LiAnne RoivainenPublished in: Molecules (Basel, Switzerland) (2018)
Amino acid residues 283-297 from sialic acid-binding immunoglobulin-like lectin 9 (Siglec-9) form a cyclic peptide ligand targeting vascular adhesion protein-1 (VAP-1). VAP-1 is associated with the transfer of leukocytes from blood to tissues upon inflammation. Therefore, analogs of Siglec-9 peptide are good candidates for visualizing inflammation non-invasively using positron emission tomography (PET). Gallium-68-labeled 1,4,7,10-tetraazacyclododecane-N,N',N″,N‴-tetraacetic acid (DOTA)-conjugated Siglec-9 has been evaluated extensively for this purpose. Here, we explored two alternative strategies for radiolabeling Siglec-9 peptide using a 1,4,7-triazacyclononane-triacetic acid (NOTA)-chelator to bind [68Ga]Ga or [18F]AlF. The radioligands were evaluated by in vivo PET imaging and ex vivo γ-counting of turpentine-induced sterile skin/muscle inflammation in Sprague-Dawley rats. Both tracers showed clear accumulation in the inflamed tissues. The whole-body biodistribution patterns of the tracers were similar.
Keyphrases
- pet ct
- pet imaging
- positron emission tomography
- oxidative stress
- computed tomography
- amino acid
- multidrug resistant
- diabetic rats
- cystic fibrosis
- escherichia coli
- photodynamic therapy
- skeletal muscle
- small molecule
- living cells
- dna binding
- high glucose
- wound healing
- soft tissue
- staphylococcus aureus
- cell migration
- fluorescent probe